almotriptan

Known as: 1-(((3-(2-(Dimethylamino)ethyl)indol-5-yl)methyl)sulfonyl)pyrrolidine, almotriptan [Chemical/Ingredient] 
A sulfonamide triptan with extracerebral, intracranial vasoconstrictor activity. Almotriptan selectively binds to and activates serotonin 5-HT 1B and… (More)
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
OBJECTIVES To assess the efficacy and safety of almotriptan 6.25 mg, 12.5 mg, and 25 mg vs placebo for acute migraine treatment… (More)
Is this relevant?
Highly Cited
2008
Highly Cited
2008
The study was designed to compare the response to almotriptan in migraine patients who take medication early in the course of the… (More)
Is this relevant?
2008
2008
OBJECTIVES To compare the clinical characteristics of menstrually related migraines (MRMs) and nonmenstrually related migraines… (More)
Is this relevant?
2007
2007
OBJECTIVE To evaluate prospectively the efficacy and safety of almotriptan 12.5 mg as compared to placebo when administered… (More)
Is this relevant?
2007
2007
Almotriptan is an orally administered, highly selective serotonin 5-HT(1(B)/1(D)) receptor agonist that is effective in the acute… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
Is this relevant?
2003
2003
OBJECTIVE To determine whether treatment of migraine with almotriptan, when pain intensity is mild, improves 1- and 2-hour pain… (More)
Is this relevant?
2002
2002
BACKGROUND Migraine sufferers typically have been instructed to delay triptan therapy until headache intensity is at least… (More)
Is this relevant?
Highly Cited
2001
Highly Cited
2001
BACKGROUND The triptans, selective serotonin 5-HT(1B/1D) agonists, are very effective acute migraine drugs with a well- developed… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2001
2001
AIMS To assess the effect of a reversible MAO-A inhibitor, moclobemide, on the single-dose pharmacokinetics of almotriptan and… (More)
Is this relevant?
2000
2000
OBJECTIVE To assess the interaction between almotriptan, a 5-HT1B/1D-receptor agonist used to treat migraine, and verapamil, an… (More)
Is this relevant?